Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2024

Sep 4, 2024

30016_dirs_2024-09-04_154022cc-20f2-4cbc-95c0-861830e38858.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-09-01

Reporting Person: Schreck Michael (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-01 Common Stock M 164 Acquired 961 Direct
2024-09-01 Common Stock F 48 $481.33 Disposed 913 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-09-01 Restricted Stock Unit $ M 164 Disposed Common Stock (164) Direct

Footnotes

F1: Includes 11 shares purchased under the Issuer's Employee Stock Purchase Plan June 28, 2024.

F2: Closing price of Issuer common stock on August 30, 2024.

F3: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments beginning on September 1, 2021.

F4: Not applicable.